Hopkins re-iterated in the radio interview that any drug candidates wouldn't be available for clinical trials for 2-3 years. Sounds like a long time but I wouldn't despair.
Referring back to the last investor presentation, the preclinical phase of development represents a major value inflexion point: Pharma are paying more for less refer slide 24. In the meantime one thing to look forward to will be the internationalisation of the company as Phylogica builds scientific and commercial collaborations.
PYC Price at posting:
1.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)